LEADER 03504nam  22005535  450 
001 9910254489203321
005 20230327180735.0
010   $a3-319-53324-X
024 7 $a10.1007/978-3-319-53324-7
035   $a(CKB)3710000001631457
035   $a(DE-He213)978-3-319-53324-7
035   $a(MiAaPQ)EBC4984675
035   $a(PPN)203852915
035   $a(EXLCZ)993710000001631457
100   $a20170823d2017      u|             0
101 0 $aeng
135   $aurnn#008mamaa
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aNon-medical Prescribing in the United Kingdom$b[electronic resource] /$fedited by Penelope Mary Franklin
205   $a1st ed. 2017.
210  1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2017.
215   $a1 online resource (XIII, 236 p. 5 illus. in color.)
311   $a3-319-53323-1 
320   $aIncludes bibliographical references at the end of each chapters and index.
330   $aThis book explores key developments in Non-medical Prescribing in the UK. Addressing the needs of countries in the European Market and beyond, which have been closely watching UK developments and would be interested in embedding or developing counterparts of their own.  Featuring chapters by clinicians, leaders and practitioners in the UK Non-medical Prescribing arena, it identifies both current and potential future developments. Attention is paid to the different prescribing practices and governance within the four countries constituting the United Kingdom.  Many lessons have been learned along the way and the purpose of this book is to share these lessons, tog ether with best practice examples in connection with the implementation of nurse/health professional led patient care, implementation of patient centered practice, and governance. Designated Registered Practitioners who have completed an enhanced training now receive a professional body qualification which enables them to prescribe within their scope of practice as Non-medical Independent Prescribers and, providing that they are competent, from anywhere within the British National Formulary independently of doctors; for Nurses, this also includes most controlled drugs. The book will be of interest to policy makers and to forward-looking professionals and practitioners in the diverse European Health and Social Care market.
606   $aNursing
606   $aPharmacotherapy
606   $aPrimary care (Medicine)
606   $aFamily medicine
606   $aNursing$3https://scigraph.springernature.com/ontologies/product-market-codes/H41005
606   $aPharmacotherapy$3https://scigraph.springernature.com/ontologies/product-market-codes/H69000
606   $aPrimary Care Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H51000
606   $aGeneral Practice / Family Medicine$3https://scigraph.springernature.com/ontologies/product-market-codes/H24003
615  0$aNursing.
615  0$aPharmacotherapy.
615  0$aPrimary care (Medicine).
615  0$aFamily medicine
615 14$aNursing.
615 24$aPharmacotherapy.
615 24$aPrimary Care Medicine.
615 24$aGeneral Practice / Family Medicine.
676   $a610.73
702   $aFranklin$b Penelope Mary$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910254489203321
996   $aNon-medical Prescribing in the United Kingdom$91760700
997   $aUNINA